| Dakota Psychiatry Clinic Pc | |
|
419 Quincy Street Rapid City SD 57701 | |
| (605) 348-6365 | |
| (605) 348-9408 |
| Full Name | Dakota Psychiatry Clinic Pc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 419 Quincy Street, Rapid City, South Dakota |
| Authorized Official Name and Position | Charles J Lord (PSYCHIATRIST) |
| Authorized Official Contact | 6053486365 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Dakota Psychiatry Clinic Pc 419 Quincy Street Rapid City SD 57701 Ph: (605) 348-6365 | Dakota Psychiatry Clinic Pc 419 Quincy Street Rapid City SD 57701 Ph: (605) 348-6365 |
| NPI Number | 1679598320 |
|---|---|
| Provider Enumeration Date | 07/13/2006 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 5193889954 |
|---|---|
| Medicare Enrollment ID | O20090123000230 |
News Archive
Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a "silent epidemic." And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a "silent population" within this epidemic.
As the United Nations prepares to recognize World Population Day on July 11, with the global population is expected to reach seven billion by October, U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin told Inter Press Service that "seven billion represents a challenge, an opportunity and a call to action."
Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.
Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer.
As the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to distress worldwide, new variants are emerging that threaten the possibility of containment by current vaccines or therapeutic antibodies.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679598320 | NPI | - | NPPES |
| 4998327 | Other | BCBS | |
| 7100080 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | SD 2247 (South Dakota) | Primary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | E2684 (Texas) | Secondary |
| Provider Name | Lisa R Kautzman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861462194 PECOS PAC ID: 1254370273 Enrollment ID: I20050428001197 |
News Archive
Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a "silent epidemic." And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a "silent population" within this epidemic.
As the United Nations prepares to recognize World Population Day on July 11, with the global population is expected to reach seven billion by October, U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin told Inter Press Service that "seven billion represents a challenge, an opportunity and a call to action."
Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.
Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer.
As the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to distress worldwide, new variants are emerging that threaten the possibility of containment by current vaccines or therapeutic antibodies.
› Verified 7 days ago
| Provider Name | Charles J Lord |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1932273190 PECOS PAC ID: 8820152655 Enrollment ID: I20090122000710 |
News Archive
Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a "silent epidemic." And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a "silent population" within this epidemic.
As the United Nations prepares to recognize World Population Day on July 11, with the global population is expected to reach seven billion by October, U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin told Inter Press Service that "seven billion represents a challenge, an opportunity and a call to action."
Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.
Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer.
As the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to distress worldwide, new variants are emerging that threaten the possibility of containment by current vaccines or therapeutic antibodies.
› Verified 7 days ago
| Provider Name | Sandra L Miller |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952344699 PECOS PAC ID: 5890988893 Enrollment ID: I20101022000684 |
News Archive
Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a "silent epidemic." And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a "silent population" within this epidemic.
As the United Nations prepares to recognize World Population Day on July 11, with the global population is expected to reach seven billion by October, U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin told Inter Press Service that "seven billion represents a challenge, an opportunity and a call to action."
Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.
Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer.
As the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to distress worldwide, new variants are emerging that threaten the possibility of containment by current vaccines or therapeutic antibodies.
› Verified 7 days ago
| Provider Name | Peggy L Oconnor |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710235213 PECOS PAC ID: 0042446841 Enrollment ID: I20150921000547 |
News Archive
Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a "silent epidemic." And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a "silent population" within this epidemic.
As the United Nations prepares to recognize World Population Day on July 11, with the global population is expected to reach seven billion by October, U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin told Inter Press Service that "seven billion represents a challenge, an opportunity and a call to action."
Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.
Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer.
As the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to distress worldwide, new variants are emerging that threaten the possibility of containment by current vaccines or therapeutic antibodies.
› Verified 7 days ago
News Archive
Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a "silent epidemic." And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a "silent population" within this epidemic.
As the United Nations prepares to recognize World Population Day on July 11, with the global population is expected to reach seven billion by October, U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin told Inter Press Service that "seven billion represents a challenge, an opportunity and a call to action."
Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.
Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer.
As the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to distress worldwide, new variants are emerging that threaten the possibility of containment by current vaccines or therapeutic antibodies.
› Verified 7 days ago
Childrens Home Society Of South Dakota Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1330 Jolly Ln, Rapid City, SD 57703 Phone: 605-343-2811 Fax: 605-341-7437 | |
Isaacs Behavioral Health, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2650 Jackson Blvd, Rapid City, SD 57702 Phone: 605-877-2010 | |
Youth & Family Services, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 202 E Adams St, Rapid City, SD 57701 Phone: 605-342-4789 | |
Mark W. Perrenoud Ph.d. Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1818 West Fulton, Suite 201, Rapid City, SD 57702 Phone: 605-348-6500 Fax: 605-341-7409 | |
Debra Hughes Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1501 Centre St, Suite 101, Rapid City, SD 57703 Phone: 605-347-1369 | |
Melissa Good, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4310 W Main St Apt 20c, Rapid City, SD 57702 Phone: 605-431-3292 | |
Cornell Counseling, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 900 Concourse Dr Ste E-227, Rapid City, SD 57703 Phone: 605-549-5433 Fax: 605-309-7919 |